TRISTEL plc
("Tristel" or the "Company")
VISICLEAN™ Product Launch
Tristel plc (AIM: TSTL), the manufacturer of infection prevention products, announces the launch of its new ultrasound probe decontamination product, Tristel VISICLEAN™, the first detergent of its kind with colour technology, enabling visible coverage and confirmation of high level disinfection.
Tristel VISICLEAN™ is deployed on the ultrasound probe, dying it pink, and when exposed to Tristel ClO₂ via Tristel DUO ULT™, the pink dye disappears, visibly verifying that the probe has been high level disinfected. Tristel VISICLEAN™ is now available within the VISI Combination Pack, a convenient, all-in-one solution for ultrasound probe decontamination. Effective high-level disinfection begins with cleaning, which eliminates organic matter and reduces microbes to ensure proper sterilisation. This is performed manually and must be done each time. Tristel VISICLEAN™ is the only cleaning solution with visible verification, ensuring full auditability and compliance with protocols.
Tristel VISICLEAN™, DUO ULT™ and DRY WIPES™, the products within the VISI Combination Pack
The VISI Combination Pack includes the Company's new product, Tristel VISICLEAN™, along with two pre-existing products, Tristel DUO ULT™ & Tristel DRY WIPES™. Together, these products enable clinicians to perform manual decontamination procedures with confidence, precision, and audit-ready traceability via Tristel's 3T™ digital platform. VISI Combination Packs are now available to healthcare providers across the UK and are being launched globally on a phased basis, as and when the Company secures the necessary local regulatory clearances.
Tristel's proprietary chlorine dioxide chemistry is globally trusted for its broad-spectrum efficacy and resistance-proof mechanism. With over 30 years of experience in high-level disinfection, Tristel continues to remain at the forefront of infection prevention.
Matt Sassone, CEO of Tristel plc, said: "We are pleased to launch Tristel VISICLEAN™, as part of the VISI Combination Pack, delivering visible cleaning, confirmed disinfection, and digital traceability, all in one intuitive kit. The scope for these products is vast and the up-sell opportunity from Tristel DUO ULT™ alone would result in 14 million cleaning procedures per annum."
For further information please contact:
|
Tristel plc |
Via Walbrook PR |
||
|
Matt Sassone, Chief Executive Officer |
|||
|
Anna Wasyl, Chief Financial Officer |
|||
|
Walbrook PR Ltd |
Tel: 020 7933 8780 or tristel@walbrookpr.com |
||
|
Paul McManus / Lianne Applegarth / Anna Dunphy |
Mob: 07980 541 893/ 07584 391 303/ 07876 741 001 |
||
|
Cavendish Capital Markets Ltd |
Tel: 020 7220 0500 |
||
|
Geoff Nash / Callum Davidson/Trisyia Jamaludin (Corporate Finance) |
|||
|
Sunila de Silva (Corporate Broking) / Louise Talbot (Sales) |
|||
About Tristel plc
Tristel plc is a global infection prevention company focussed on the manufacture and supply of products using its unique proprietary chlorine dioxide (ClO2) chemistry. The Company is a market leader in manual decontamination of medical devices, supplying hospitals under the Tristel brand, and under the Cache brand provides products for sporicidal surface disinfection, a more sustainable alternative to commonly used pre-wetted plastic wipes.
Tristel's head office and manufacturing facility is located in Snailwell, near Cambridge, and operates globally employing approximately 270 people across 16 subsidiaries selling into 40+ countries. The Company targets double digit revenue growth annually and an EBITDA margin of at least 25% and the business is profitable, with no debt and has a progressive dividend policy.
The Company has been listed on the London Stock Exchange's AIM market since 2005 (AIM: TSTL).
For more information about Tristel's product range please visit: https://tristel.com